The Enterprise Value as of December 2024 (TTM) for Innate Pharma S.A. (IPHA) is 125.62M

According to Innate Pharma S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 125.62M. This represents a change of -19.51% compared to the average of 156.06M of the last 4 quarters.

Innate Pharma S.A. (IPHA) Historical Enterprise Value (quarterly & annually)

How has IPHA Enterprise Value performed in the past?

The mean historical Enterprise Value of Innate Pharma S.A. over the last ten years is 303.51M. The current 125.62M Enterprise Value has changed 4.04% with respect to the historical average. Over the past ten years (40 quarters), IPHA's Enterprise Value was at its highest in in the December 2015 quarter at 794.33M. The Enterprise Value was at its lowest in in the September 2022 quarter at 124.44M.

Innate Pharma S.A. (IPHA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Innate Pharma S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Innate Pharma S.A. (IPHA) Average Enterprise Value

How has IPHA Enterprise Value performed in the past?

The current Enterprise Value of Innate Pharma S.A. (IPHA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Innate Pharma S.A. (IPHA) Enterprise Value vs. Peers

How is IPHA’s Enterprise Value compared to its peers?

Innate Pharma S.A.’s Enterprise Value is less than Eliem Therapeutics, Inc. (0), greater than HCW Biologics Inc. (26.89M), greater than Inhibrx Biosciences, Inc. (14.97M), greater than Anebulo Pharmaceuticals, Inc. (31.01M), greater than Pardes Biosciences, Inc. (75.90M), greater than Shattuck Labs, Inc. (12.30M), greater than Champions Oncology, Inc. (116.09M), greater than Century Therapeutics, Inc. (88.73M), greater than Addex Therapeutics Ltd (7.35M), greater than Aptorum Group Limited (5.08M), greater than Celyad Oncology SA (24.59M), greater than Dyadic International, Inc. (52.41M), greater than Molecular Partners AG (107.67M), greater than MediciNova, Inc. (61.90M), greater than Cyteir Therapeutics, Inc. (-20511738.00),

Build a custom stock screener for Innate Pharma S.A. (IPHA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Innate Pharma S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Innate Pharma S.A. (IPHA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Innate Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.